Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02642042 |
|---|---|
| Brief Title: | Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer |
| First Submitted : | December 29, 2015 |
| First Submitted that Met QC Criteria : | December 29, 2015 |
| First Posted : | December 30, 2015 (Estimate) |
| Results First Submitted : | December 1, 2020 |
| Results First Submitted that Met QC Criteria : | January 13, 2021 |
| Results First Posted : | February 2, 2021 |
| Last Update Submitted that Met QC Criteria : | May 15, 2024 |
| Last Update Posted : | May 16, 2024 (Estimate) |